PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
21549688-0	2011	The tyrosine kinase inhibitor sorafenib sensitizes hepatocellular carcinoma cells to taxol by suppressing the HURP protein.	Sorafenib	30-39	DLG associated protein 5	Homo sapiens	110-114	
21549688-6	2011	Notably, sorafenib, a tyrosine kinase inhibitor approved for the treatment of HCC, inhibits HURP expression primarily at the transcriptional level and sensitizes HCC cells to sub-lethal doses of taxol.	Sorafenib	9-18	DLG associated protein 5	Homo sapiens	92-96	
21549688-8	2011	In addition, the inhibitory effect of sorafenib on HURP expression was attributed to a reduced translation and nuclear translocation of c-Rel.	Sorafenib	38-47	DLG associated protein 5	Homo sapiens	51-55